Munich, Germany

Christine Laqmani-Goffinet

This inventor holds 1 USPTO granted patent and 1 published patent application, plus 1 CIPO patent and 1 EPO patent. Top assignees: Helmholtz-Zentrum Fur Infektionsforschung Gmbh, Medizinische Hochschule Hannover, Twincore, Zentrum Fur Experimentelle Und Klinische Infektionsforschung Gmbh. Active years: 2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christine Laqmani-Goffinet. Retrieved from https://idiyas.com/inventor/christine-laqmani-goffinet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0


 

Average Co-Inventor Count = 11.0

ph-index = 1


Company Filing History:


Years Active: 2022

Loading Chart...
Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christine Laqmani-Goffinet: Innovator in Anti-Viral Research

Introduction

Christine Laqmani-Goffinet is a notable inventor based in Munich, Germany. She has made significant contributions to the field of anti-viral agents through her innovative research. Her work focuses on developing novel labyrinthopeptin derivatives that have the potential to treat various infectious diseases.

Latest Patents

Christine holds a patent for "Labyrinthopeptins as anti-viral agents." This invention relates to novel labyrinthopeptin derivatives that are useful for treating infectious diseases caused by viruses such as human respiratory syncytial virus (RSV), Kaposi sarcoma-associated herpesvirus (KSHV), cytomegalovirus (CMV), dengue virus (DENV), chikungunya virus (CHIKV), tick-borne encephalitis virus (TBEV), vesicular stomatitis Indiana virus (VSV), zika virus (ZIKV), and hepatitis C virus (HCV). The labyrinthopeptin derivatives are also valuable for analyzing the mode of action of labyrinthopeptins. Furthermore, the invention includes a combination of labyrinthopeptin A1 and A2 for use as a medicament in treating infectious diseases.

Career Highlights

Christine has worked with prominent research institutions, including Helmholtz Zentrum für Infektionsforschung GmbH and Medizinische Hochschule Hannover. Her career reflects a strong commitment to advancing medical research and developing effective treatments for viral infections.

Collaborations

Christine has collaborated with esteemed colleagues such as Mark Brönstrup and Hans-Peter Prochnow. These partnerships have enhanced her research and contributed to the success of her innovative projects.

Conclusion

Christine Laqmani-Goffinet is a pioneering inventor whose work in anti-viral research is making a significant impact in the medical field. Her dedication to developing effective treatments for infectious diseases showcases her valuable contributions to science and innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…